HROW Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Harrow Inc. Stock Analysis HROW
United States Health Care Small Cap Report: Harrow, Inc. engages in the development, production, and sale of innovative medications. The company is headquartered in Nashville, Tennessee and currently employs 382 full-time employees. The company went IPO on 2013-02-08. The firm is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. The company provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. The company owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. The company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. The company owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.
Read More Harrow Inc (HROW) Chart
Harrow Inc (HROW) vs S&P 500 Comparative Returns
Analysis of Harrow Inc (HROW) stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Harrow Inc (HROW) 13.95%
- S&P 500 8.2%
Harrow Inc Outperformed S&P 500 by 5.75%
1Y Performance
- Harrow Inc (HROW) -3.17%
- S&P 500 17.63%
Harrow Inc Underperformed S&P 500 by 20.80%
3Y Performance
- Harrow Inc (HROW) 346.61%
- S&P 500 54.54%
Harrow Inc Outperformed S&P 500 by 292.07%
5Y Performance
- Harrow Inc (HROW) 465.53%
- S&P 500 94.73%
Harrow Inc Outperformed S&P 500 by 370.80%
Key Statistics of Harrow Inc (HROW)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$38.20Volume
606.57KP/E Ratio (TTM)
-52 Week Range
Market Cap
1.33BAvg. Volume
647.13KDividend Yield
-Financial Metrics & Statements of Harrow Inc (HROW)
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 1.9 | 2.69 | 2.96 | 3.7 | - |
EBIT per Share (TTM) | 0.03 | 0.07 | 0.06 | 0.02 | - |
Earnings per Share (EPS) (TTM) | -0.13 | - | -0.51 | -0.75 | - |
Dividend per Share (TTM) | - | 0 | 0 | - | - |
EPS Forward | - | - | -0.51 | -0.75 | -0.49 |
Annual 
Quarterly
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Net Margin | -0.07 | -0.25 | -0.16 | -0.19 | -0.09 |
Quick Ratio | 3.37 | 5.7 | 5.83 | 2.45 | 1.83 |
Current Ratio | 3.8 | 6.26 | 6.36 | 2.83 | 2.08 |
Price to Earnings (TTM) | 0 | 0 | 0 | 0 | 0 |
price_to_earning | 0 | 0 | 0 | 0 | 0 |
Price to Sales (TTM) | 0 | 0 | 0 | 0 | 0 |
Price to Book | 6.49 | 20.57 | 14.66 | 5.56 | 17.15 |
Free Cash Flow Margin | 0 | 0.05 | 0 | 0 | 0 |
Payout Ratio (TTM) | 0 | 0 | 0 | 0 | 0 |
Gross Margin | 0.7 | 0.75 | 0.71 | 0.7 | 0.75 |
Return on Equity (TTM) | 0 | 0 | 0 | 0 | 0 |
Return on Assets | -0.06 | -0.18 | -0.09 | -0.08 | -0.04 |
Return on Assets (TTM) | 0 | 0 | 0 | 0 | 0 |
Return on Invested Capital | -0.08 | -0.22 | -0.11 | -0.1 | -0.06 |
Inventory Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Receivables Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Asset Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt to Equity | 0.46 | 6.35 | 3.78 | 2.59 | 3.15 |
Total Debt to Total Asset | 0.28 | 0.73 | 0.66 | 0.59 | 0.56 |
Long-Term Debt to Total Asset | 0.22 | 0.73 | 0.66 | 0.59 | 0.56 |
Total Debt to Total Capital | 0.37 | 0.86 | 0.79 | 0.72 | 0.76 |
Operating Margin | 0.01 | 0.04 | 0.02 | -0.04 | 0.04 |
Price to Earning | -52.77 | - | -28.94 | -14.93 | - |
Super Investors Invested in Harrow Inc (HROW)
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Community-Curated Collections with Harrow Inc (HROW)
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
shariah list nifty 50
By trading view
2122 Followers
HALAL STOCK of india
By Aasif Khan
1886 Followers
My Halal AI Stocks Technology - 2024
By Doniyor Akhmadjon
662 Followers
Recent Halal Top Performers US
By Doniyor Akhmadjon
445 Followers
Dow Jones Industrial Average Index
By Dilnoza Mirsaidova
235 Followers
Zero Debt Stocks in India
By Javokhir Suyundikov
123 Followers
1st HALAL NIFTY SMALLCAP 250
By Abdul Mannan
113 Followers
Halal stocks in INDIA
By Altaf Khan
111 Followers
IT Sector Stocks in India
By Javokhir Suyundikov
107 Followers
Halal Divident Stock
By Monirul Islam
100 Followers
FAQ's for Harrow Inc (HROW)
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks for Harrow Inc (HROW)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
